Ventricular Tachycardia in Ischemic Cardiomyopathy; a Combined Endo-Epicardial Ablation Within the First procedure Versus a Stepwise Approach a randomized controlled trial

Ventricular Tachycardia in Ischemic Cardiomyopathy; a Combined Endo-Epicardial Ablation Within the First procedure Versus a Stepwise Approach a randomized controlled trial - Epilogue

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON53074

Enrollment

Registered

2015-02-17

Start date

2015-07-27

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ventricular tachycardia

Interventions

Combined endo/epicardial substrate homogenization in a first approach

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. clinical indication for ablation of a monomorphic ventricular tachycardia referred to one of the participating ablation centers 2. history of ischemic heart disease 3. ICD carrier or ICD implantation planned after the ablation 4. informed written consent

Exclusion criteria

Exclusion criteria: 1. current unstable angina 2. AMI

Design outcomes

Primary

Measure	Time frame
The main study endpoint is the difference in recurrences of ventricular tachycardia on follow-up - clinical or on ICD interrogation - between the two ablation groups	—

Secondary

Measure	Time frame
Procedure success and safety.	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)